AEON Biopharma (AEON) Earnings Date & Reports

AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AEON is expected to report earnings to fall 77.43% to -64 cents per share on August 18

AEON Biopharma AEON Stock Earnings Reports

Q2'26

Est.

$-0.65

Q4'25

Missed

by $2.64

Q3'25

Missed

by $0.07

Q2'25

Missed

by $0.29

Q1'25

Beat

by $2.57

The last earnings report on March 30 showed earnings per share of -288 cents, missing the estimate of -23 cents. With 2.22K shares outstanding, the current market capitalization sits at 17.34M.

View a ticker or compare two or three

Compare

AEON

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for AEON